JPRN-UMIN000011670已完成未知
Randomized, open label, controlled clinical trial of eldcalcitol for falls prevention in postmenopausal osteoporotic patients with depression. - Efficacy of eldcalcitol for falls prevention in postmenopausal osteoporotic patients with depression.
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
研究概览
简要总结
none
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 50years-old 至 95years-old（—）
- 性别
- Female
入选标准
- 未提供
排除标准
- •Patients who are diagnosed as contraindication of raloxifene treatments Patients who are diagnosed as contraindication of eldecalcitol treatments Patient who have a past history of treatment with vitamin D within 6 months Patient who have a past history of treatment for osteoporosis besides vitamin D in the past 12-months Unsuitable for trial as evaluated by the physician-in-charge Subject who refuse to participate in this study
研究者
相似试验
进行中（未招募）
1 期
Assessment of anticancer therapy-related cognitive impairment in breast cancer patients and evaluation of integrated therapy effects with rehabilitation exercises, diet and add-on complementary medicinePrimary diagnosis of breast cancer (stage: I-III A) treated with adjuvant chemotherapy and / or endocrine therapy after surgical treatment.MedDRA version: 20.0Level: SOCClassification code 10038604Term: Reproductive system and breast disordersSystem Organ Class: 10038604 - Reproductive system and breast disordersEUCTR2020-003176-40-ITAZIENDA USL TOSCANA NORD OVEST320
尚未招募
3 期
A study to compare the efficacy of Gomutra Haritaki Nitya Virechana along with Udvartana and Triphala Kashaya Nitya Virechana along with Udvartana in the management of Sthaulya Or Obesity.CTRI/2024/06/068875Dr Sridhar Babu K V
尚未招募
3 期
Study of efficacy of Aamalaki Kwath in treatment of Mutrakruchhra with special reference to cystitisCTRI/2023/06/053893Dr. Sujata Prataprao Chavhan
尚未招募
2 期
Test the effect of Tab. Thiriphala Chooranam in pre diabetic populatioCTRI/2016/10/007396Dr M Kannan60
招募中
3 期
A clinical trial to compare the effect of Single Transition from Enbrel® Auto-Injector (AI) to YLB113 Auto-Injector in Patients with Active Rheumatoid Arthritis (RA).CTRI/2019/01/016851upin Limited Biotechnology Division